Open AccessPedsQL Eosinophilic Esophagitis Module
Author(s) -
Franciosi James P.,
Hommel Kevin A.,
Bendo Cristiane B.,
King Eileen C.,
Collins Margaret H.,
Eby Michael D.,
Marsolo Keith,
Abonia J. Pablo,
Tiehl Karl F.,
Putnam Philip E.,
Greenler Alexandria J.,
Greenberg Allison B.,
Bryson Ronald A.,
Davis Carla M.,
Olive Anthony P.,
Gupta Sandeep K.,
Erwin Elizabeth A.,
Klinnert Mary D.,
Spergel Jonathan M.,
Denham Jolanda M.,
Furuta Glenn T.,
Rothenberg Marc E.,
Varni James W.
Publication year - 2013
Publication title -
journal of pediatric gastroenterology and nutrition
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.206
H-Index - 131
eISSN - 1536-4801
pISSN - 0277-2116
DOI - 10.1097/mpg.0b013e31828f1fd2
Subject(s) - medicine , intraclass correlation , eosinophilic esophagitis , quality of life (healthcare) , proxy (statistics) , gastroenterology , disease , psychometrics , clinical psychology , nursing , machine learning , computer science
Objective: Eosinophilic esophagitis (EoE) is a chronic esophageal inflammatory condition with a paucity of information on health‐related quality of life (HRQOL). The objective of the study was to report on the measurement properties of the PedsQL EoE Module. Methods: The PedsQL EoE Module was completed in a multisite study by 196 pediatric patients with EoE and 262 parents of patients with EoE. Results: The PedsQL EoE Module scales evidenced excellent feasibility (0.6%–3.1% missing), excellent group comparison reliability across total scale scores (patient α 0.93; parent proxy α 0.94), good reliability for the 7 individual scales (patient α 0.75–0.87; parent proxy α 0.81–0.92), excellent test–retest reliability (patient intraclass correlation coefficient 0.88; parent intraclass correlation coefficient 0.82), demonstrated no floor effects and low ceiling effects, and demonstrated a high percentage of scaling success for most scales. Intercorrelations with the PedsQL Generic Core Scales were in the medium (0.30) to large (0.50) range. PedsQL EoE Module scores were worse among patients with active histologic disease (≥5 eos/hpf) compared with those in remission (patient self‐report: 63.3 vs 69.9 [ P < 0.05]; parent proxy report: 65.1 vs 72.3 [ P < 0.01]), and those treated with dietary restrictions compared with those with no restrictions (patient self‐report: 61.6 vs 74.3 [ P < 0.01]; parent proxy report: 65.5 vs 74.7 [ P < 0.01]). Conclusions: The results demonstrate excellent measurement properties of the PedsQL EoE Module. Patients with active histologic disease and those treated with dietary restrictions demonstrated worse PedsQL scores. The PedsQL EoE Module may be used in the evaluation of pediatric EoE disease‐specific HRQOL in clinical research and practice.